ID 8985
File
Authors
Harada, Tomoya Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University / Division of Respirology, Tsuyama Daiichi Hospital Researchers DB
Kawasaki, Yuji Division of Respirology, Tsuyama Daiichi Hospital
Tsukada, Akira Department of Clinical Laboratory, Tsuyama Daiichi Hospital
Osawa, Yoichi Department of Clinical Laboratory, Tsuyama Daiichi Hospital
Takami, Hiroki Division of Respirology, Tsuyama Daiichi Hospital
Yamaguchi, Kosuke Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University Researchers DB KAKEN
Kurai, Jun Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University Researchers DB KAKEN
Yamasaki, Akira Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University Researchers DB KAKEN
Shimizu, Eiji Division of Medical Oncology and Molecular Respirology, Faculty of Medicine, Tottori University KAKEN
Keywords
Paragonimiasis westermani
pulmonary paragonimiasis
bronchodilator reversibility
asthma
eosinophil
Abstract
A 43-year-old woman was referred to our hospital with peripheral blood hypereosinophilia and abnormal chest X-ray findings. Her pleural effusion revealed hypereosinophilia and a low glucose level. She was diagnosed with pulmonary paragonimiasis based on an elevated antibody level of Paragonimiasis westermani. Although she had no medical history of allergic disorders, a pulmonary function test revealed bronchodilator reversibility. After praziquantel therapy, her symptoms, hypereosinophilia in peripheral blood, and pleural effusion were improved. A repeated pulmonary function test after praziquantel therapy showed a negative bronchodilator response. Pulmonary paragonimiasis may induce bronchodilator reversibility during the acute phase of infection.
Publisher
The Japanese Society of Internal Medicine
Content Type
Journal Article
Link
ISSN
09182918
EISSN
13497235
Journal Title
INTERNAL MEDICINE
Volume
58
Issue
2
Start Page
297
End Page
300
Published Date
2019
Publisher-DOI
Text Version
Publisher
Rights
The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-Non Commercial - No Derivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Citation
Harada Tomoya, Kawasaki Yuji, Tsukada Akira, et al. Bronchodilator Reversibility Occurring during the Acute Phase of Paragonimiasis westermani Infection. INTERNAL MEDICINE. 2019. 58(2). 297-300. doi:10.2169/internalmedicine.0401-17
Department
Faculty of Medicine/Graduate School of Medical Sciences/University Hospital
Language
English
Web of Science Key ut
WOS:000455930700024